Description: Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. The company offers various oral solid dose, liquids, semi-solids, steriles, biologicals, and active pharmaceutical ingredients. It also provides various therapeutic products, including general anaesthetics and muscle relaxants; and injectable anticoagulants comprising orgaran for the treatment of HIT and heparin based products under the Thrombosis brand. In addition, the company offers oncology, endocrinology, and women's health products, as well as nutritional infant milks. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Home Page: www.aspenpharma.com
Aspen Place
Durban,
South Africa
Phone:
27 31 580 8600
Officers
| Name | Title |
|---|---|
| Mr. Stephen Bradley Saad | Group CEO & Exec. Director |
| Mr. Sean M. Capazorio | Group CFO & Exec. Director |
| Ms. Lorraine Hill | Group Chief Operations Officer & Responsible Pharmacist |
| Mr. Michael Guy Attridge B.Com., BCom, CA(SA) | Group Chief Advisor |
| Mr. Reginald Haman Grad. Dip., MBA, ND, NHD, PGDBA | Group Chief Corp. Services Officer |
| Ms. Zizipho Mmango | Group Chief Strategic Devel. Officer |
| Mr. Riaan Verster ACIS, BProc, L.L.B., L.L.M., LLB, LLM | Company Sec., Group Governance Officer & Group Compliance Officer |
| Mr. Trevor Julian Ziman | Regional Chief Exec. Officer of Asia Pacific |
| Mr. Stavros Nicolaou | Group Sr. Exec. of Strategic Trade |
| Mr. Carnie van der Linde | Group Commercial Head |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 9.6429 |
| Price-to-Book MRQ: | 0.9824 |
| Price-to-Sales TTM: | 0.1049 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 8580 |